Vitalhub Corp. (TSE:VHI – Get Free Report)’s share price dropped 2.6% during mid-day trading on Thursday . The company traded as low as C$7.20 and last traded at C$7.23. Approximately 187,463 shares changed hands during trading, a decline of 48% from the average session volume of 357,574 shares. The stock had previously closed at C$7.42.
Analyst Upgrades and Downgrades
VHI has been the topic of several research reports. Raymond James Financial decreased their price target on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. National Bank Financial dropped their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$13.14.
Check Out Our Latest Stock Report on Vitalhub
Vitalhub Stock Down 1.8%
Vitalhub (TSE:VHI – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%.The company had revenue of C$31.91 million during the quarter. Research analysts forecast that Vitalhub Corp. will post 0.2296467 EPS for the current fiscal year.
Insider Activity
In related news, Director Steve Garrington sold 10,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of C$7.17, for a total value of C$71,700.00. Following the completion of the sale, the director owned 50,000 shares of the company’s stock, valued at approximately C$358,500. This represents a 16.67% decrease in their ownership of the stock. Corporate insiders own 18.57% of the company’s stock.
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
- Five stocks we like better than Vitalhub
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
